| Autor: |
Palacios-Fuenmayor, L.J., Naranjo-Isaza, A.M., Serna-Ortiz, C.A., Mosquera-Castro, D.A., Arbeláez-Leon, L.M., Gómez-Wolff, L.R., García-García, H.I., Sánchez-Patiño, L.A. |
| Zdroj: |
Revista de Gastroenterología de México (English Version); January-March 2021, Vol. 86 Issue: 1 p13-20, 8p |
| Abstrakt: |
Neoadjuvant therapy in rectal cancer is associated with a decrease in tumor size and is the therapeutic indication for patients with T3 or T4 tumors or lymph node involvement. Our aim was to describe the frequency of pathologic response and the survival rate in patients that underwent neoadjuvant therapy for rectal cancer. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
